# SpringLeaf Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/springleaf-therapeutics

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.springleaftx.com
- Total disclosed funding: $31M
- Latest round: Series B (Jul 8, 2011)
- Investors on record: 4

## About

Founded in 2007, SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on convergent science and is designed to enable and differentiate therapeutics.

## Funding rounds

- Series B, Jul 8, 2011, $4M — Excel Venture Management
- Series B, Apr 27, 2011, $15M — North Bridge Venture Partners, SR One, Flybridge Capital Partners
- Series A, Nov 1, 2008, $12M — North Bridge Venture Partners, Flybridge Capital Partners

## Investors

- North Bridge Venture Partners (https://capitalatlas.ai/funds/north-bridge-venture-partners) — Series A, Series B
- Flybridge Capital Partners (https://capitalatlas.ai/funds/flybridge-capital-partners) — Series A, Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- Excel Venture Management (https://capitalatlas.ai/funds/excel-venture-management) — Series B